These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11278505)

  • 41. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
    Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
    Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.
    Skolnik EY; Lee CH; Batzer A; Vicentini LM; Zhou M; Daly R; Myers MJ; Backer JM; Ullrich A; White MF
    EMBO J; 1993 May; 12(5):1929-36. PubMed ID: 8491186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors.
    Yonezawa K; Ando A; Kaburagi Y; Yamamoto-Honda R; Kitamura T; Hara K; Nakafuku M; Okabayashi Y; Kadowaki T; Kaziro Y
    J Biol Chem; 1994 Feb; 269(6):4634-40. PubMed ID: 7508445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Gu H; Maeda H; Moon JJ; Lord JD; Yoakim M; Nelson BH; Neel BG
    Mol Cell Biol; 2000 Oct; 20(19):7109-20. PubMed ID: 10982827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells.
    Nakajima K; Yamauchi K; Shigematsu S; Ikeo S; Komatsu M; Aizawa T; Hashizume K
    J Biol Chem; 2000 Jul; 275(27):20880-6. PubMed ID: 10764799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactive roles of Ras, insulin receptor substrate-1, and proteins with Src homology-2 domains in insulin signaling in Xenopus oocytes.
    Chuang LM; Hausdorff SF; Myers MG; White MF; Birnbaum MJ; Kahn CR
    J Biol Chem; 1994 Nov; 269(44):27645-9. PubMed ID: 7961682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways.
    Kao AW; Waters SB; Okada S; Pessin JE
    Endocrinology; 1997 Jun; 138(6):2474-80. PubMed ID: 9165038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
    Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
    J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and Shc in HEK 293 cells.
    Strack V; Bossenmaier B; Stoyanov B; Mushack J; Häring HU
    Diabetologia; 1997 Oct; 40(10):1135-40. PubMed ID: 9349593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3'-kinase activity.
    Dupont J; Derouet M; Simon J; Taouis M
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):293-300. PubMed ID: 9761726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation.
    Ouwens DM; van der Zon GC; Pronk GJ; Bos JL; Möller W; Cheatham B; Kahn CR; Maassen JA
    J Biol Chem; 1994 Dec; 269(52):33116-22. PubMed ID: 7806540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
    Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
    J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of farnesyltransferase and geranylgeranyltransferase I by caspase-3: cleavage of the common alpha subunit during apoptosis.
    Kim KW; Chung HH; Chung CW; Kim IK; Miura M; Wang S; Zhu H; Moon KD; Rha GB; Park JH; Jo DG; Woo HN; Song YH; Kim BJ; Yuan J; Jung YK
    Oncogene; 2001 Jan; 20(3):358-66. PubMed ID: 11313965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation.
    Boney CM; Smith RM; Gruppuso PA
    Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.